Antihypertensive Market

Antihypertensive Market aims to provide a comprehensive presentation of the global market for Antihypertensive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antihypertensive. Antihypertensive Market contains market size and forecasts of Antihypertensive in global, including the following market information:
Global Antihypertensive Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antihypertensive Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Antihypertensive companies in 2022 (%)
The global Antihypertensive market was valued at US$ 19810 million in 2022 and is projected to reach US$ 22820 million by 2029, at a CAGR of 2.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increase in blood pressure is measured in terms of systolic and diastolic blood pressure exerted by blood on the wall of artery and hence it is also termed as arterial hypertension. Reduction in blood pressure minimizes the risk of heart failure, ischaemic heart diseases, dementia and mortality due to hypertension.
We surveyed the Antihypertensive manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antihypertensive Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Antihypertensive Market Segment Percentages, by Type, 2022 (%)
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Calcium Channel Blockers
Beta Blockers
Alpha Blockers
Vasodilators & Renin Inhibitors
Global Antihypertensive Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Antihypertensive Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Others
Global Antihypertensive Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Antihypertensive Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antihypertensive revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Antihypertensive revenues share in global market, 2022 (%)
Key companies Antihypertensive sales in global market, 2018-2023 (Estimated), (Units)
Key companies Antihypertensive sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Norvatis
Merck & Co.
Sanofi
AstraZeneca
GSK
Daiichi-Sankyo
Boehringer-Ingelheim
Bayer
Johnson & Johnson
Bristol-Myers Squibb
Tekeda
Ranbaxy Laboratories
Shihuida Pharm
Second Pharmaceutical
Lupin Limited.
Yangtze River Pharmaceutical
Hengrui Medicine
Qilu Pharmaceutical
HUALON
Dawnrays
HISUN Pharmceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antihypertensive, market overview.
Chapter 2: Global Antihypertensive market size in revenue and volume.
Chapter 3: Detailed analysis of Antihypertensive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antihypertensive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antihypertensive capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.